Table 4 Incidence of adverse events in the two study groups from inclusion to day 7 of follow up
Day 1 | Day 2 | Day 3 | Day 7 | |||||
|---|---|---|---|---|---|---|---|---|
Adverse event | AM | AL | AM | AL | AM | AL | AM | MF |
Dizziness (n,%) | 35 (22.3) | 17 (11.1) | 61 (38.8) | 8 (5.2) | 58 (38.1) | 11 (7.1) | 15 (10.2) | 6 (4.03) |
Vomit (n,%) | 16 (10.2) | 11 (7.2) | 09 (5.7) | 0 | 04 (2.6) | 0 | 0 | 0 |
Abdominal pain | 15 (9.5) | 11 (7.2) | 11 (7.2) | 10 (6.5) | 10 (6.5) | 4 (2.6) | 1 (0.66) | 0 |
Pruritus (n,%) | 0 | 2 (1.3) | 0 | 1 (0.6) | 0 | 0 | 0 | 0 |
Oral herpes (n,%) | 0 | 2 (1.3) | 0 | 3 (1.9) | 1 (0.66) | 3 (1.9) | 0 | 1 (0.67) |